12:00 AM
Dec 22, 1997
 |  BC Week In Review  |  Company News  |  Deals

Alpha 1 Biomedicals, SciClone deal

SCLN acquired worldwide rights to ALBM's Zadaxin immunomodulator, which it previously had licensed from ALBM. SCLN will no...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >